COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir
NCT04321174
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
123
Enrollment
OTHER
Sponsor class
Conditions
Coronavirus Infections
Post-exposure Prophylaxis
Interventions
DRUG:
Lopinavir/ritonavir
Sponsor
Unity Health Toronto